RECRUITING

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Talk to us

Conditions

Acute Lymphoblastic Leukemia, Pediatric

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

Official Title

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Quick Facts

Study Start:2024-12-01
Study Completion:2027-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06074666

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:3 Years to 9 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
  2. * Parent has primary medication responsibility.
  3. * Pediatric patient aged 3-9 years
  4. * Child on therapy that includes home-based oral anti-cancer medication taken at home, such as 6-MP.
  5. * Parent has verbal English or Spanish fluency.
  6. * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
  1. * Parent of a child who is not diagnosed nor being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
  2. * Parent does not have primary medication responsibility.
  3. * Pediatric patient aged 3-9 years
  4. * Pediatric patient is not on therapy that includes oral anti-cancer medication (e.g., 6-MP).
  5. * Parent does not have verbal English or Spanish fluency.
  6. * Parent is unwilling or unable to follow protocol requirements

Contacts and Locations

Study Contact

Elizabeth Bouchard, PhD
CONTACT
716-845-1300
Elizabeth.Bouchard@roswellpark.rog

Principal Investigator

Elizabeth Bouchard, PhD
PRINCIPAL_INVESTIGATOR
Roswell Park Comprehensive Cancer Center

Study Locations (Sites)

Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263
United States

Collaborators and Investigators

Sponsor: Roswell Park Cancer Institute

  • Elizabeth Bouchard, PhD, PRINCIPAL_INVESTIGATOR, Roswell Park Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-01
Study Completion Date2027-10-01

Study Record Updates

Study Start Date2024-12-01
Study Completion Date2027-10-01

Terms related to this study

Additional Relevant MeSH Terms

  • Acute Lymphoblastic Leukemia, Pediatric